Studien
Studien in Durchführung:
CLEARANCE
Young ESUS
SOCRATES
NAVIGATE ESUS
Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) (NAVIGATE ESUS)
clinicaltrials.gov/ct2/show/NCT02313909
CLOSURE-AF
Perkutaner Verschluss des linken Vorhofohres bei Patienten mit Vorhofflimmern und hohem Schlaganfall- und Blutungsrisiko im Vergleich zur medikamentösen Standardtherapie
SUNRISE-2
Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms (SUNRISE-2)
clinicaltrials.gov/ct2/show/NCT02415010
MonDAFIS
Impact of standardised MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS)
Ziel: Mehrtägiges EKG Monitoring bei akuten Schlaganfallpatienten zum Nachweis von Vorhofflimmern
clinicaltrials.gov/ct2/show/NCT02204267
RE-SPECT ESUS
Randomized, double-blind evaluation in secondary stroke prevention comparing the efficacy and safety of the thrombin inhibitor dabigatran etexilate 110 or 150 mg (twice daily) versus acetylsalicytic acid (100mg once daily) in patients with controlled clinical trial Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
Ziel: Vergleich von ASS versus Dabigatran bei Patienten mit kryptogenem Schlaganfall
clinicaltrials.gov/ct2/show/NCT02239120?term=respect+esus&rank=1
Schlaganfallregister RASUNOA-Prime
(Register Akuter Schlaganfall unter neuen oralen Antikoagulanzien)
clinicaltrials.gov/ct2/show/NCT02533960?term=rasunoa+prime&rank=1